Vistas | |
---|---|
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study | 146 |
noviembre 2024 | diciembre 2024 | enero 2025 | febrero 2025 | marzo 2025 | abril 2025 | mayo 2025 | |
---|---|---|---|---|---|---|---|
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study | 1 | 1 | 1 | 8 | 7 | 14 | 3 |
Vistas |
---|
Vistas |
---|